Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1215666.RAQcCSgiOFBQDjM5XQRlzbgdCysGa94xme9xsEXsfYaLY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1215666.RAQcCSgiOFBQDjM5XQRlzbgdCysGa94xme9xsEXsfYaLY130_assertion type Assertion NP1215666.RAQcCSgiOFBQDjM5XQRlzbgdCysGa94xme9xsEXsfYaLY130_head.
- NP1215666.RAQcCSgiOFBQDjM5XQRlzbgdCysGa94xme9xsEXsfYaLY130_assertion description "[In addition, in the human ESCC cell line (EC-1) in�vitro, TGF-?1 treatment markedly induced EMT, including morphological alterations, a decrease of E-cadherin and an increase of vimentin levels and enhanced mobility and invasiveness.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215666.RAQcCSgiOFBQDjM5XQRlzbgdCysGa94xme9xsEXsfYaLY130_provenance.
- NP1215666.RAQcCSgiOFBQDjM5XQRlzbgdCysGa94xme9xsEXsfYaLY130_assertion evidence source_evidence_literature NP1215666.RAQcCSgiOFBQDjM5XQRlzbgdCysGa94xme9xsEXsfYaLY130_provenance.
- NP1215666.RAQcCSgiOFBQDjM5XQRlzbgdCysGa94xme9xsEXsfYaLY130_assertion SIO_000772 25175594 NP1215666.RAQcCSgiOFBQDjM5XQRlzbgdCysGa94xme9xsEXsfYaLY130_provenance.
- NP1215666.RAQcCSgiOFBQDjM5XQRlzbgdCysGa94xme9xsEXsfYaLY130_assertion wasDerivedFrom befree-2016 NP1215666.RAQcCSgiOFBQDjM5XQRlzbgdCysGa94xme9xsEXsfYaLY130_provenance.
- NP1215666.RAQcCSgiOFBQDjM5XQRlzbgdCysGa94xme9xsEXsfYaLY130_assertion wasGeneratedBy ECO_0000203 NP1215666.RAQcCSgiOFBQDjM5XQRlzbgdCysGa94xme9xsEXsfYaLY130_provenance.